Information about Globipharm
My details
*
*
*

Globipharm (SRL)

Company information

Status
Active

Enterprise number

BE0843.002.254

VAT liability
Yes
Established
19-01-2012
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Activities of agents involved in the wholesale of food, beverages and tobacco
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Globipharm

2024 2023 2022 2021
Profit/Loss 19,641 -34 % 29,955 -17 % 35,881 -23 % 46,346
Equity 74,437 36 % 54,796 22 % 44,841 400 % 8,960
Gross margin 69,752 -16 % 83,252 7 % 77,472 -22 % 99,903

Publications from Globipharm

Date Publication
28-03-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations - Appointments (NL)
04-12-2017 Registered Office (NL)
20-02-2017 Resignations - Appointments (NL)
06-02-2012 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Globipharm?
The VAT number of Globipharm is BE 0843.002.254.
Wat is the PEPPOL ID of Globipharm?
The PEPPOL ID of Globipharm is 0208:0843002254. Log in or start a free trial to see the full overview.
When was Globipharm founded?
Globipharm was founded on 19-01-2012.
What is the address of Globipharm?
The current registered office of Globipharm is located at Satenrozen 6A/2, 2550 Kontich.
When was the last time Globipharm filed their annual financial statements?
The most recent financial statements of Globipharm were filed on 03-05-2025.
How many employees does Globipharm have?
There are currently no employees working at Globipharm or no workforce information is available.
What is the annual turnover of Globipharm?
At the time of its most recent financial statements, Globipharm did not publish any turnover figures. Globipharm reported a gross margin of €69,752.16.